According to forecasts, the Intraosseous Infusion Devices Market would be valued US$ 4.4 billion in 2023 and US$ 8.6 billion by 2033. Sales of intraosseous infusion devices are anticipated to grow at a significant CAGR of 6.9% over the course of the anticipated year.
The market has been growing as a result of an increase in emergency cases. These situations involve health issues such as strokes, seizures, burns, unexpected breathing difficulties, and others where the use of intraosseous infusion devices is crucial. When there are no intravenous entry points and medicine must be given through a bone marrow entry point, intraosseous infusion devices are used.
In a typical medical operation, intravenous fluid and drug delivery is a top choice since it is more affordable and comfortable than intraosseous infusion. However, the demand for intraosseous infusion is anticipated to expand as the demand for high-volume, quick infusions during emergencies rises.
Get Recently Updated Report of Market as Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1569
The first line of defence in cardiac arrest resuscitation is defibrillation, and if it fails, titrated adrenaline is given through the sternum via an intraosseous infusion device. The market for IO infusion devices is anticipated to experience growth because to the increasing frequency of cardiovascular disorders.
To enhance the quality of patient care, healthcare organisations frequently work with hospitals, healthcare professionals, and service suppliers. Consequently, providing high quality treatment together with cutting-edge technologies will further fuel the market as a whole during the projection period.
The hospitals are concentrating on boosting investment in R&D in order to enhance revenue share. Therefore, it is anticipated that industry participants will profit from the market’s lucrative rise during the forecast period.
Such advancements not only improve the company’s current portfolio but also help them become more visible locally and globally, enabling them to withstand the growing competitive pressure.
Key Takeaways from Intraosseous Infusion Devices Market Study
- By product, EZ-IO holds the maximum share of 20% in the market in 2021, expanding at 6.4% CAGR during the forecast period.
- By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
- By technology, the automatic segment will account for more than 50.8% of the market share in 2021.
- By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.
“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst
Contact our Market Research Specialist @ https://www.futuremarketinsights.com/ask-question/rep-gb-1569
Who is winning?
Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.
- Cook Medical: Every medical profession we offer has two common threads: patients who want to be healthy and clinicians who desire more user-friendly tools. As a result, we devote significant resources to designing, manufacturing, and delivering a differentiated range of minimally invasive medical devices to healthcare systems worldwide.
- Becton Dickinson and Company: With a product line that fulfils the needs of patients, we want to increase physician satisfaction while also assisting hospitals and surgery centres in improving results and lowering expenses. BD has refined surgical instruments and led to improved results for more than a century. with a substantial portfolio and a track record of supplying high-quality items
The key market players covered by FMI include
- Pyng Medical Corp.
- Biopsybell
- Cook Medical Incorporated
- PAVmed
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Company
- SAM Medical
- Cardinal Health, Inc
Share Your Requirements & Get Customized Reports @ https://www.futuremarketinsights.com/customization-available/rep-gb-1569
Intraosseous Infusion Devices – Market by Category
Product:
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
By Route of Administration:
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
By Technology:
- Manual
- Automatic
- Impact Driven
- Power Drill
Inquire Before Buying This Research Report @ https://www.futuremarketinsights.com/checkout/1569
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
